Nucleoside-Analog-2
CAT:
804-HY-77652-03
Size:
10 mM / 1 mL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Nucleoside-Analog-2
- CAS Number: 876708-01-9
- UNSPSC Description: Nucleoside-Analog-2 is a 4'-Azidocytidine analogue against Hepatitis C virus (HCV) replication. Nucleoside-Analog-2 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
- Target Antigen: HCV; Nucleoside Antimetabolite/Analog
- Type: Reference compound
- Related Pathways: Anti-infection;Cell Cycle/DNA Damage
- Applications: COVID-19-anti-virus
- Field of Research: Infection
- Assay Protocol: https://www.medchemexpress.com/Nucleoside-Analog-2.html
- Purity: 95.0
- Solubility: DMSO : 33.33 mg/mL (ultrasonic)|H2O : 20 mg/mL (ultrasonic)
- Smiles: O[C@@H]1[C@](CO)(N=[N+]=[N-])O[C@@H](N2C(NC(C=C2)=O)=O)[C@H]1O
- Molecular Weight: 285.21354
- References & Citations: [1]Smith DB, et al. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. J Med Chem. 2009 Jan 8;52(1):219-23.
- Shipping Conditions: Room Temperature
- Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
- Clinical Information: No Development Reported